Egypt, Qatar intensify coordination as Gaza crisis worsens    Egypt prepares governmental talks with Germany to boost economic cooperation    Arabia Developments, ElSewedy join forces to launch industrial zone in New 6th of October City    Egypt, US's Merit explore local production of medical supplies, export expansion    Egypt, WHO discuss joint plans to support crisis-affected health sectors    IWG accelerates Egypt expansion, plans 30 new flexible workspace centres in 2026    Grand Egyptian Museum fuels hospitality, real estate expansion in West Cairo    400 children with disabilities take part in 'Their Right to Joy' marathon    Egypt touts North Coast as investment magnet after $29.7b Qatar deal – FinMin    URGENT: Egypt's net FX reserves hit $50b in October – CBE    Egypt's Foreign Minister discusses Gaza, Sudan with Russian counterpart    Russia's Putin appoints new deputy defence minister in security shake-up    UNESCO General Conference elects Egypt's El-Enany, first Arab to lead body    Egypt repatriates 36 smuggled ancient artefacts from the US    Grand Egyptian Museum attracts 18k visitors on first public opening day    'Royalty on the Nile': Grand Ball of Monte-Carlo comes to Cairo    Egypt, Albania discuss expanding healthcare cooperation    VS-FILM Festival for Very Short Films Ignites El Sokhna    Egypt's cultural palaces authority launches nationwide arts and culture events    Egypt launches Red Sea Open to boost tourism, international profile    Qatar to activate Egypt investment package with Matrouh deal in days: Cabinet    Hungary, Egypt strengthen ties as Orbán anticipates Sisi's 2026 visit    Egypt's PM pledges support for Lebanon, condemns Israeli strikes in the south    Omar Hisham Talaat: Media partnership with 'On Sports' key to promoting Egyptian golf tourism    Egypt, Medipha sign MoU to expand pharmaceutical compounding, therapeutic nutrition    Egypt establishes high-level committee, insurance fund to address medical errors    Sisi expands national support fund to include diplomats who died on duty    Madinaty Golf Club to host 104th Egyptian Open    Egypt's PM reviews efforts to remove Nile River encroachments    Al-Sisi: Cairo to host Gaza reconstruction conference in November    Egypt will never relinquish historical Nile water rights, PM says    Al-Sisi, Burhan discuss efforts to end Sudan war, address Nile Dam dispute in Cairo talks    Syria releases preliminary results of first post-Assad parliament vote    Egypt resolves dispute between top African sports bodies ahead of 2027 African Games    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Whistleblower: Trump official ignored warning on drug, virus
Published in Ahram Online on 05 - 05 - 2020

A government scientist says he was ousted from his position after raising concerns that the Trump administration wanted to ``flood'' coronavirus hot spots like New York and New Jersey with a malaria drug that President Donald Trump was pushing despite scant scientific evidence it helped.
Rick Bright, former director of the Biomedical Advanced Research and Development Authority, filed the complaint Tuesday with the Office of Special Counsel, a government agency responsible for whistleblower complaints. He alleges he was reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by Trump.
Bright also said the Trump administration rejected his warnings on COVID-19, the disease caused by the virus. Bright said he ``acted with urgency'' to address the growing spread of COVID-19 after the World Health Organization issued a warning in January.
He said he ``encountered resistance from HHS leadership, including Health and Human Services Secretary Alex Azar, who appeared intent on downplaying this catastrophic event.''
Bright alleges in the complaint that political appointees at the Department of Health and Human Services had tried to promote hydroxychloroquine ``as a panacea.'' The officials also ``demanded that New York and New Jersey be `flooded' with these drugs, which were imported from factories in Pakistan and India that had not been inspected by the FDA,'' the complaint says.
But Bright opposed broad use of the drug, arguing the scientific evidence wasn't there to back up its use in coronavirus patients. He felt an urgent need to tell the public that there wasn't enough scientific evidence to support using the drugs for COVID-19 patients, the complaint states.
Last month, the U.S. Food and Drug Administration warned doctors against prescribing the drug except in hospitals and research studies. In an alert, regulators flagged reports of sometimes fatal heart side effects among coronavirus patients taking hydroxychloroquine or the related drug chloroquine.
The decades-old drugs, also prescribed for lupus and rheumatoid arthritis, can cause a number of side effects, including heart rhythm problems, severely low blood pressure and muscle or nerve damage.


Clic here to read the story from its source.